Header cover image
  • Investing Ideas
  • /
  • French Pharmaceuticals & Biotech Undervalued based on future growth

French Pharmaceuticals & Biotech Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Boiron

Market Cap: €403.7m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

BOI

€23.25

7D

1.1%

1Y

-33.0%